GLP-1s Protect Against Stroke, Alzheimer’s Disease
GENETIC evidence has suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may protect against Alzheimer’s disease and stroke, particularly…
Browsing Category